Resistance to thyroid hormone due to defective thyroid receptor alpha

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• Thyroid hormones regulate metabolism via nuclear receptors (TRα1, TRβ1, TRβ2).
• The role of TRα2 protein, co-expressed with TRα1, remains unclear.
• Resistance to thyroid hormone alpha (RTHα) presents as tissue-specific hypothyroidism with atypical thyroid function tests.

Purpose of the Study:

• To characterize the clinical and biochemical features of RTHα.
• To investigate the genetic basis of RTHα, focusing on TRα1 and TRα2.
• To highlight the potential benefits of early diagnosis and treatment for RTHα.

Main Methods:

• Analysis of clinical phenotypes, including dysmorphic facies, skeletal dysplasia, and developmental delays.
• Biochemical assessment of thyroid hormone levels (T4, T3, reverse T3) and muscle creatine kinase.
• Genetic analysis, including whole exome sequencing, to identify mutations in thyroid hormone receptor genes.

Main Results:

• RTHα is associated with specific clinical features like macrocephaly, growth retardation, and intellectual deficit.
• Biochemical findings include low T4, high T3, a low T4/T3 ratio, and elevated muscle creatine kinase.
• Heterozygous loss-of-function mutations in TRα1, or both TRα1 and TRα2, mediate RTHα, with no distinct phenotype linked to TRα2 deficiency.

Conclusions:

• Whole exome sequencing and biomarkers can improve RTHα diagnosis.
• Thyroxine therapy can ameliorate metabolic abnormalities, growth, and developmental issues in RTHα patients.
• Further research is needed to understand the genetic and phenotypic heterogeneity and optimize RTHα management.